|
ARFGEF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.387400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.633900E-04 |
| Normal-vs-Stage2 |
9.583400E-01 |
| Normal-vs-Stage3 |
1.537630E-02 |
| Normal-vs-Stage4 |
4.955600E-03 |
| Stage1-vs-Stage2 |
1.369680E-02 |
| Stage1-vs-Stage3 |
4.764800E-01 |
| Stage1-vs-Stage4 |
7.229600E-01 |
| Stage2-vs-Stage3 |
6.051900E-02 |
| Stage2-vs-Stage4 |
1.662370E-02 |
| Stage3-vs-Stage4 |
3.950600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.682060E-03 |
| Normal-vs-AfricanAmerican |
5.440400E-02 |
| Normal-vs-Asian |
1.141440E-03 |
| Caucasian-vs-AfricanAmerican |
7.384400E-01 |
| Caucasian-vs-Asian |
1.727810E-01 |
| AfricanAmerican-vs-Asian |
5.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.318400E-03 |
| Normal-vs-Female |
2.164500E-03 |
| Male-vs-Female |
3.985800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583230E-04 |
| Normal-vs-Age(41-60Yrs) |
2.709600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.635800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.809800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.096000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.711990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.467400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.694400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.720800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.772600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.484200E-01 |
| Classical-VS-Follicular |
2.31639999959121E-07 |
| Classical-VS-Other |
4.434800E-01 |
| Classical-VS-Normal |
1.60799999999739E-05 |
| Tall-VS-Follicular |
5.570800E-04 |
| Tall-VS-Other |
2.702200E-01 |
| Tall-VS-Normal |
1.356100E-03 |
| Follicular-VS-Other |
3.744800E-01 |
| Follicular-VS-Normal |
5.523600E-01 |
| Other-VS-Normal |
3.606400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.040300E-02 |
| Normal-vs-N1 |
1.823960E-02 |
| N0-vs-N1 |
1.765170E-01 |
|
|
